{"id":"W4380729666","doi":"10.1093/ecco-jcc/jjad100","title":"Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McMaster University; Population Health Research Institute; Western University","funders":"UCB Pharma; Allergan; Genentech; ActoGeniX; Celltrion; Teva Pharmaceutical Industries; Gilead Sciences; Mylan; Celgene; Biogen; GlaxoSmithKline; Takeda Oncology; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Relative risk; Placebo; Gastroenterology; Ulcerative colitis; Inflammatory bowel disease; Meta-analysis; Randomized controlled trial; Crohn's disease; Clinical trial; Confidence interval; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008119125,0.00038745,0.003634699,0.00017686,0.00007003792,0.00004485967,0.0002011594,0.0001595963,0.00000931746],"category_scores_gemma":[0.0004796315,0.0002748424,0.001646973,0.0001265888,0.0001303021,0.000009888048,0.0001280816,0.0001220908,4.328025e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001513846,"about_ca_system_score_gemma":0.0002571889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.624449e-7,"about_ca_topic_score_gemma":0.00001121587,"domain_scores_codex":[0.9973945,0.0003342592,0.001553847,0.0003181443,0.0001883671,0.0002109085],"domain_scores_gemma":[0.9972011,0.0001269108,0.001658078,0.0003665909,0.000328571,0.0003187434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0005731126,0.00002973985,0.000003531439,0.9338408,0.0630742,0.000169842,0.000009833683,0.000007348411,7.70297e-7,0.0001629254,0.0001302416,0.001997657],"study_design_scores_gemma":[0.0007730713,0.0001524729,0.003355045,0.03304559,0.9190997,0.00009938402,0.00001942169,0.000005922245,0.000001416535,0.0000510765,0.04293392,0.0004629522],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005733783,0.9967661,0.0001001444,0.00003685326,0.0000264585,0.001832666,0.0006533222,0.000003823326,0.000007259995],"genre_scores_gemma":[0.0001174422,0.9989234,0.0002546584,0.00009409292,0.00004586476,0.0001711639,0.0000773046,0.00004554261,0.0002704931],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9007952,"threshold_uncertainty_score":0.9999704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0320333354844749,"score_gpt":0.3136903146730268,"score_spread":0.2816569791885519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}